Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference virtual-strategy.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from virtual-strategy.com Daily Mail and Mail on Sunday newspapers.
Pulmonx Corporation , a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2023 after the close of. | April 18, 2023
Pulmonx Co. (NASDAQ:LUNG – Get Rating) has received a consensus recommendation of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. The average […]
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating on […]
Pulmonx (NASDAQ:LUNG – Get Rating) had its price target boosted by Citigroup from $12.00 to $13.00 in a report published on Monday, The Fly reports. They currently have a buy rating on the stock. A number of other analysts have also commented on the company. Morgan Stanley lifted their target price on Pulmonx from $9.50 […]